Mersana Therapeutics
MRSN
MRSN
46 hedge funds and large institutions have $198M invested in Mersana Therapeutics in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 21 increasing their positions, 8 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
42% less capital invested
Capital invested by funds: $342M → $198M (-$144M)
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Holders
46
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$5.89M | |
| 2 | +$4.96M | |
| 3 | +$2.47M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.54M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$315K |
Top Sellers
| 1 | -$10.7M | |
| 2 | -$2.53M | |
| 3 | -$1.03M | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$766K |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$465K |